Deltex Medical up on higher revenue, strong interest in new monitor
22/12/2022 13:42
** Shares of UK-based medical technology co Deltex Medical
Group DEMG.L rise 19.3% to 0.92p
** DEMG stock touches highest level since Oct 13, headed for
best day since Jan 2021
** DEMG says its year-to-date revenues are ahead of its
full-year 2021 revenue figures
** Co says operating costs lower than originally
anticipated; confirms cash support from its largest shareholder
and chairman Nigel Keen
** DEMG reports "strong" interest in its new TrueVue
monitor, which uses haemodynamic monitoring technology to assist
clinicians to improve outcomes for patients
** Launch of new monitor delayed for "several more weeks"
due to pending regulatory approvals and testing completion held
back due to global supply chain disruption, adds co
** "Group has already won a tender in respect of new monitor
at a price point significantly higher than price levels
typically achieved for current monitor" - Deltex
** Stock down ~35% so far this year
(Reporting by Muhammed Husain in Bengaluru)
((Muhammed.Husain@thomsonreuters.com;))